Genprex, Inc.
Datakwaliteit: 83%
GNPX
Nasdaq
Manufacturing
Chemicals
€ 1,30
▼
€ 0,01
(-0,76%)
Marktkapitalisatie: 11,76 M
Prijs
€ 1,30
Marktkapitalisatie
11,76 M
Dagbereik
€ 1,27 — € 1,36
52-Weeksbereik
€ 1,26 — € 55,00
Volume
347.675
Openen € 1,29
50D / 200D Gem.
€ 2,04
36,42% below
50D / 200D Gem.
€ 6,88
81,10% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -15,31 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-1503,38%
Onder sectorgemiddelde (-53,41%)
ROIC-1020,59%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,67
Interest CoverageN/A
Waardering
PE (TTM)
-0,72
Boven sectorgemiddelde (-1,48)
P/B Ratio15,31
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,7 | -1,5 |
| P/B | 15,3 | 1,6 |
| ROE % | -1503,4 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -16,23 M |
| ROE | -1503,38% | ROA | -439,21% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -15,31 M |
| ROIC | -1020,59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,67 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -836.605 | Tangible Book Value | 767.807 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,72 | Forward P/E | N/A |
| P/B Ratio | 15,31 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -130,22% | ||
| Market Cap | 11,76 M | Enterprise Value | 10,65 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -1,69 | OCF / Share | -1,69 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 94,35% |
| SBC-Adj. FCF | -15,92 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -16,23 M | -21,11 M | -30,86 M | -23,74 M | -19,60 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -15,52 M | -21,17 M | -31,08 M | -23,83 M | -19,60 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9,43 M | 10,54 M | 17,62 M | 11,51 M | 8,61 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | 2.650,0 | 0,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10,16 M | 4,12 M | 10,67 M | 25,09 M | 42,86 M |
| Total Liabilities | 2,20 M | — | — | 2,46 M | — |
| Shareholders' Equity | 7,96 M | 1,62 M | 7,42 M | 22,27 M | 41,28 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 7,83 M | 1,60 M | 6,74 M | — | — |
| Current Assets | 8,36 M | 2,08 M | 7,53 M | 21,47 M | 39,14 M |
| Current Liabilities | 2,17 M | 2,50 M | 3,25 M | 2,81 M | 1,59 M |
{"event":"ticker_viewed","properties":{"ticker":"GNPX","listing_kind":"stock","pathname":"/stocks/gnpx","exchange":"Nasdaq","country":"US"}}